 | • レポートコード：MRC2-11QY04840 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は子宮頸がん治療法・診断のグローバル市場について調査・分析したレポートです。種類別（パパニコロウ塗抹検査、コルポスコピー検査、ECC手順）市場規模、用途別（製薬会社、病院および診療所、民間および政府の研究所、学術機関）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別子宮頸がん治療法・診断の競争状況、市場シェア ・世界の子宮頸がん治療法・診断市場：種類別市場規模 2015年-2020年（パパニコロウ塗抹検査、コルポスコピー検査、ECC手順） ・世界の子宮頸がん治療法・診断市場：種類別市場規模予測 2021年-2026年（パパニコロウ塗抹検査、コルポスコピー検査、ECC手順） ・世界の子宮頸がん治療法・診断市場：用途別市場規模 2015年-2020年（製薬会社、病院および診療所、民間および政府の研究所、学術機関） ・世界の子宮頸がん治療法・診断市場：用途別市場規模予測 2021年-2026年（製薬会社、病院および診療所、民間および政府の研究所、学術機関） ・北米の子宮頸がん治療法・診断市場分析：米国、カナダ ・ヨーロッパの子宮頸がん治療法・診断市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの子宮頸がん治療法・診断市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の子宮頸がん治療法・診断市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの子宮頸がん治療法・診断市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Abbott Laboratories、Becton、Dickenson、Roche Diagnostics、Johnson and Johnson、Merck、Pfizer、Bristol-Myers Squibb、Digene、Dendreon、SANOFI ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Therapies and Diagnostics for Cervical Cancer refers to a series of methods and medical devices that can be used for the diagnosis and treatment of cervical cancer.
The factors that are driving the cervical cancer market are HPV infection, women having many sexual partners, women getting sexually active at an early age, smoking, certain genetic factors and weak immune system.
Market Analysis and Insights: Global Therapies and Diagnostics for Cervical Cancer Market
The global Therapies and Diagnostics for Cervical Cancer market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Therapies and Diagnostics for Cervical Cancer Scope and Market Size
Therapies and Diagnostics for Cervical Cancer market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Therapies and Diagnostics for Cervical Cancer market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Abbott Laboratories
Becton
Dickenson
Roche Diagnostics
Johnson and Johnson
Merck
Pfizer
Bristol-Myers Squibb
Digene
Dendreon
SANOFI
Market segment by Type, the product can be split into
Pap Smear Tests
Colposcopy Tests
ECC Procedure
Market segment by Application, split into
Drug Manufacturers
Hospitals and Clinics
Private and Government Research Institutes
Academic Institutes
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Therapies and Diagnostics for Cervical Cancer Revenue
1.4 Market by Type
1.4.1 Global Therapies and Diagnostics for Cervical Cancer Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Pap Smear Tests
1.4.3 Colposcopy Tests
1.4.4 ECC Procedure
1.5 Market by Application
1.5.1 Global Therapies and Diagnostics for Cervical Cancer Market Share by Application: 2020 VS 2026
1.5.2 Drug Manufacturers
1.5.3 Hospitals and Clinics
1.5.4 Private and Government Research Institutes
1.5.5 Academic Institutes
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Therapies and Diagnostics for Cervical Cancer Market Perspective (2015-2026)
2.2 Global Therapies and Diagnostics for Cervical Cancer Growth Trends by Regions
2.2.1 Therapies and Diagnostics for Cervical Cancer Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Therapies and Diagnostics for Cervical Cancer Historic Market Share by Regions (2015-2020)
2.2.3 Therapies and Diagnostics for Cervical Cancer Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Therapies and Diagnostics for Cervical Cancer Market Growth Strategy
2.3.6 Primary Interviews with Key Therapies and Diagnostics for Cervical Cancer Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Therapies and Diagnostics for Cervical Cancer Players by Market Size
3.1.1 Global Top Therapies and Diagnostics for Cervical Cancer Players by Revenue (2015-2020)
3.1.2 Global Therapies and Diagnostics for Cervical Cancer Revenue Market Share by Players (2015-2020)
3.1.3 Global Therapies and Diagnostics for Cervical Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Therapies and Diagnostics for Cervical Cancer Market Concentration Ratio
3.2.1 Global Therapies and Diagnostics for Cervical Cancer Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Therapies and Diagnostics for Cervical Cancer Revenue in 2019
3.3 Therapies and Diagnostics for Cervical Cancer Key Players Head office and Area Served
3.4 Key Players Therapies and Diagnostics for Cervical Cancer Product Solution and Service
3.5 Date of Enter into Therapies and Diagnostics for Cervical Cancer Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Therapies and Diagnostics for Cervical Cancer Historic Market Size by Type (2015-2020)
4.2 Global Therapies and Diagnostics for Cervical Cancer Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Therapies and Diagnostics for Cervical Cancer Market Size by Application (2015-2020)
5.2 Global Therapies and Diagnostics for Cervical Cancer Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Therapies and Diagnostics for Cervical Cancer Market Size (2015-2020)
6.2 Therapies and Diagnostics for Cervical Cancer Key Players in North America (2019-2020)
6.3 North America Therapies and Diagnostics for Cervical Cancer Market Size by Type (2015-2020)
6.4 North America Therapies and Diagnostics for Cervical Cancer Market Size by Application (2015-2020)
7 Europe
7.1 Europe Therapies and Diagnostics for Cervical Cancer Market Size (2015-2020)
7.2 Therapies and Diagnostics for Cervical Cancer Key Players in Europe (2019-2020)
7.3 Europe Therapies and Diagnostics for Cervical Cancer Market Size by Type (2015-2020)
7.4 Europe Therapies and Diagnostics for Cervical Cancer Market Size by Application (2015-2020)
8 China
8.1 China Therapies and Diagnostics for Cervical Cancer Market Size (2015-2020)
8.2 Therapies and Diagnostics for Cervical Cancer Key Players in China (2019-2020)
8.3 China Therapies and Diagnostics for Cervical Cancer Market Size by Type (2015-2020)
8.4 China Therapies and Diagnostics for Cervical Cancer Market Size by Application (2015-2020)
9 Japan
9.1 Japan Therapies and Diagnostics for Cervical Cancer Market Size (2015-2020)
9.2 Therapies and Diagnostics for Cervical Cancer Key Players in Japan (2019-2020)
9.3 Japan Therapies and Diagnostics for Cervical Cancer Market Size by Type (2015-2020)
9.4 Japan Therapies and Diagnostics for Cervical Cancer Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Therapies and Diagnostics for Cervical Cancer Market Size (2015-2020)
10.2 Therapies and Diagnostics for Cervical Cancer Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Therapies and Diagnostics for Cervical Cancer Market Size by Type (2015-2020)
10.4 Southeast Asia Therapies and Diagnostics for Cervical Cancer Market Size by Application (2015-2020)
11 India
11.1 India Therapies and Diagnostics for Cervical Cancer Market Size (2015-2020)
11.2 Therapies and Diagnostics for Cervical Cancer Key Players in India (2019-2020)
11.3 India Therapies and Diagnostics for Cervical Cancer Market Size by Type (2015-2020)
11.4 India Therapies and Diagnostics for Cervical Cancer Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Therapies and Diagnostics for Cervical Cancer Market Size (2015-2020)
12.2 Therapies and Diagnostics for Cervical Cancer Key Players in Central & South America (2019-2020)
12.3 Central & South America Therapies and Diagnostics for Cervical Cancer Market Size by Type (2015-2020)
12.4 Central & South America Therapies and Diagnostics for Cervical Cancer Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Abbott Laboratories
13.1.1 Abbott Laboratories Company Details
13.1.2 Abbott Laboratories Business Overview
13.1.3 Abbott Laboratories Therapies and Diagnostics for Cervical Cancer Introduction
13.1.4 Abbott Laboratories Revenue in Therapies and Diagnostics for Cervical Cancer Business (2015-2020))
13.1.5 Abbott Laboratories Recent Development
13.2 Becton
13.2.1 Becton Company Details
13.2.2 Becton Business Overview
13.2.3 Becton Therapies and Diagnostics for Cervical Cancer Introduction
13.2.4 Becton Revenue in Therapies and Diagnostics for Cervical Cancer Business (2015-2020)
13.2.5 Becton Recent Development
13.3 Dickenson
13.3.1 Dickenson Company Details
13.3.2 Dickenson Business Overview
13.3.3 Dickenson Therapies and Diagnostics for Cervical Cancer Introduction
13.3.4 Dickenson Revenue in Therapies and Diagnostics for Cervical Cancer Business (2015-2020)
13.3.5 Dickenson Recent Development
13.4 Roche Diagnostics
13.4.1 Roche Diagnostics Company Details
13.4.2 Roche Diagnostics Business Overview
13.4.3 Roche Diagnostics Therapies and Diagnostics for Cervical Cancer Introduction
13.4.4 Roche Diagnostics Revenue in Therapies and Diagnostics for Cervical Cancer Business (2015-2020)
13.4.5 Roche Diagnostics Recent Development
13.5 Johnson and Johnson
13.5.1 Johnson and Johnson Company Details
13.5.2 Johnson and Johnson Business Overview
13.5.3 Johnson and Johnson Therapies and Diagnostics for Cervical Cancer Introduction
13.5.4 Johnson and Johnson Revenue in Therapies and Diagnostics for Cervical Cancer Business (2015-2020)
13.5.5 Johnson and Johnson Recent Development
13.6 Merck
13.6.1 Merck Company Details
13.6.2 Merck Business Overview
13.6.3 Merck Therapies and Diagnostics for Cervical Cancer Introduction
13.6.4 Merck Revenue in Therapies and Diagnostics for Cervical Cancer Business (2015-2020)
13.6.5 Merck Recent Development
13.7 Pfizer
13.7.1 Pfizer Company Details
13.7.2 Pfizer Business Overview
13.7.3 Pfizer Therapies and Diagnostics for Cervical Cancer Introduction
13.7.4 Pfizer Revenue in Therapies and Diagnostics for Cervical Cancer Business (2015-2020)
13.7.5 Pfizer Recent Development
13.8 Bristol-Myers Squibb
13.8.1 Bristol-Myers Squibb Company Details
13.8.2 Bristol-Myers Squibb Business Overview
13.8.3 Bristol-Myers Squibb Therapies and Diagnostics for Cervical Cancer Introduction
13.8.4 Bristol-Myers Squibb Revenue in Therapies and Diagnostics for Cervical Cancer Business (2015-2020)
13.8.5 Bristol-Myers Squibb Recent Development
13.9 Digene
13.9.1 Digene Company Details
13.9.2 Digene Business Overview
13.9.3 Digene Therapies and Diagnostics for Cervical Cancer Introduction
13.9.4 Digene Revenue in Therapies and Diagnostics for Cervical Cancer Business (2015-2020)
13.9.5 Digene Recent Development
13.10 Dendreon
13.10.1 Dendreon Company Details
13.10.2 Dendreon Business Overview
13.10.3 Dendreon Therapies and Diagnostics for Cervical Cancer Introduction
13.10.4 Dendreon Revenue in Therapies and Diagnostics for Cervical Cancer Business (2015-2020)
13.10.5 Dendreon Recent Development
13.11 SANOFI
10.11.1 SANOFI Company Details
10.11.2 SANOFI Business Overview
10.11.3 SANOFI Therapies and Diagnostics for Cervical Cancer Introduction
10.11.4 SANOFI Revenue in Therapies and Diagnostics for Cervical Cancer Business (2015-2020)
10.11.5 SANOFI Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Therapies and Diagnostics for Cervical Cancer Key Market Segments
Table 2. Key Players Covered: Ranking by Therapies and Diagnostics for Cervical Cancer Revenue
Table 3. Ranking of Global Top Therapies and Diagnostics for Cervical Cancer Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Therapies and Diagnostics for Cervical Cancer Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Pap Smear Tests
Table 6. Key Players of Colposcopy Tests
Table 7. Key Players of ECC Procedure
Table 8. Global Therapies and Diagnostics for Cervical Cancer Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Therapies and Diagnostics for Cervical Cancer Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Therapies and Diagnostics for Cervical Cancer Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Therapies and Diagnostics for Cervical Cancer Market Share by Regions (2015-2020)
Table 12. Global Therapies and Diagnostics for Cervical Cancer Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Therapies and Diagnostics for Cervical Cancer Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Therapies and Diagnostics for Cervical Cancer Market Growth Strategy
Table 18. Main Points Interviewed from Key Therapies and Diagnostics for Cervical Cancer Players
Table 19. Global Therapies and Diagnostics for Cervical Cancer Revenue by Players (2015-2020) (Million US$)
Table 20. Global Therapies and Diagnostics for Cervical Cancer Market Share by Players (2015-2020)
Table 21. Global Top Therapies and Diagnostics for Cervical Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Therapies and Diagnostics for Cervical Cancer as of 2019)
Table 22. Global Therapies and Diagnostics for Cervical Cancer by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Therapies and Diagnostics for Cervical Cancer Product Solution and Service
Table 25. Date of Enter into Therapies and Diagnostics for Cervical Cancer Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Therapies and Diagnostics for Cervical Cancer Market Size by Type (2015-2020) (Million US$)
Table 28. Global Therapies and Diagnostics for Cervical Cancer Market Size Share by Type (2015-2020)
Table 29. Global Therapies and Diagnostics for Cervical Cancer Revenue Market Share by Type (2021-2026)
Table 30. Global Therapies and Diagnostics for Cervical Cancer Market Size Share by Application (2015-2020)
Table 31. Global Therapies and Diagnostics for Cervical Cancer Market Size by Application (2015-2020) (Million US$)
Table 32. Global Therapies and Diagnostics for Cervical Cancer Market Size Share by Application (2021-2026)
Table 33. North America Key Players Therapies and Diagnostics for Cervical Cancer Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Therapies and Diagnostics for Cervical Cancer Market Share (2019-2020)
Table 35. North America Therapies and Diagnostics for Cervical Cancer Market Size by Type (2015-2020) (Million US$)
Table 36. North America Therapies and Diagnostics for Cervical Cancer Market Share by Type (2015-2020)
Table 37. North America Therapies and Diagnostics for Cervical Cancer Market Size by Application (2015-2020) (Million US$)
Table 38. North America Therapies and Diagnostics for Cervical Cancer Market Share by Application (2015-2020)
Table 39. Europe Key Players Therapies and Diagnostics for Cervical Cancer Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Therapies and Diagnostics for Cervical Cancer Market Share (2019-2020)
Table 41. Europe Therapies and Diagnostics for Cervical Cancer Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Therapies and Diagnostics for Cervical Cancer Market Share by Type (2015-2020)
Table 43. Europe Therapies and Diagnostics for Cervical Cancer Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Therapies and Diagnostics for Cervical Cancer Market Share by Application (2015-2020)
Table 45. China Key Players Therapies and Diagnostics for Cervical Cancer Revenue (2019-2020) (Million US$)
Table 46. China Key Players Therapies and Diagnostics for Cervical Cancer Market Share (2019-2020)
Table 47. China Therapies and Diagnostics for Cervical Cancer Market Size by Type (2015-2020) (Million US$)
Table 48. China Therapies and Diagnostics for Cervical Cancer Market Share by Type (2015-2020)
Table 49. China Therapies and Diagnostics for Cervical Cancer Market Size by Application (2015-2020) (Million US$)
Table 50. China Therapies and Diagnostics for Cervical Cancer Market Share by Application (2015-2020)
Table 51. Japan Key Players Therapies and Diagnostics for Cervical Cancer Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Therapies and Diagnostics for Cervical Cancer Market Share (2019-2020)
Table 53. Japan Therapies and Diagnostics for Cervical Cancer Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Therapies and Diagnostics for Cervical Cancer Market Share by Type (2015-2020)
Table 55. Japan Therapies and Diagnostics for Cervical Cancer Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Therapies and Diagnostics for Cervical Cancer Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Therapies and Diagnostics for Cervical Cancer Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Therapies and Diagnostics for Cervical Cancer Market Share (2019-2020)
Table 59. Southeast Asia Therapies and Diagnostics for Cervical Cancer Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Therapies and Diagnostics for Cervical Cancer Market Share by Type (2015-2020)
Table 61. Southeast Asia Therapies and Diagnostics for Cervical Cancer Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Therapies and Diagnostics for Cervical Cancer Market Share by Application (2015-2020)
Table 63. India Key Players Therapies and Diagnostics for Cervical Cancer Revenue (2019-2020) (Million US$)
Table 64. India Key Players Therapies and Diagnostics for Cervical Cancer Market Share (2019-2020)
Table 65. India Therapies and Diagnostics for Cervical Cancer Market Size by Type (2015-2020) (Million US$)
Table 66. India Therapies and Diagnostics for Cervical Cancer Market Share by Type (2015-2020)
Table 67. India Therapies and Diagnostics for Cervical Cancer Market Size by Application (2015-2020) (Million US$)
Table 68. India Therapies and Diagnostics for Cervical Cancer Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Therapies and Diagnostics for Cervical Cancer Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Therapies and Diagnostics for Cervical Cancer Market Share (2019-2020)
Table 71. Central & South America Therapies and Diagnostics for Cervical Cancer Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Therapies and Diagnostics for Cervical Cancer Market Share by Type (2015-2020)
Table 73. Central & South America Therapies and Diagnostics for Cervical Cancer Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Therapies and Diagnostics for Cervical Cancer Market Share by Application (2015-2020)
Table 75. Abbott Laboratories Company Details
Table 76. Abbott Laboratories Business Overview
Table 77. Abbott Laboratories Product
Table 78. Abbott Laboratories Revenue in Therapies and Diagnostics for Cervical Cancer Business (2015-2020) (Million US$)
Table 79. Abbott Laboratories Recent Development
Table 80. Becton Company Details
Table 81. Becton Business Overview
Table 82. Becton Product
Table 83. Becton Revenue in Therapies and Diagnostics for Cervical Cancer Business (2015-2020) (Million US$)
Table 84. Becton Recent Development
Table 85. Dickenson Company Details
Table 86. Dickenson Business Overview
Table 87. Dickenson Product
Table 88. Dickenson Revenue in Therapies and Diagnostics for Cervical Cancer Business (2015-2020) (Million US$)
Table 89. Dickenson Recent Development
Table 90. Roche Diagnostics Company Details
Table 91. Roche Diagnostics Business Overview
Table 92. Roche Diagnostics Product
Table 93. Roche Diagnostics Revenue in Therapies and Diagnostics for Cervical Cancer Business (2015-2020) (Million US$)
Table 94. Roche Diagnostics Recent Development
Table 95. Johnson and Johnson Company Details
Table 96. Johnson and Johnson Business Overview
Table 97. Johnson and Johnson Product
Table 98. Johnson and Johnson Revenue in Therapies and Diagnostics for Cervical Cancer Business (2015-2020) (Million US$)
Table 99. Johnson and Johnson Recent Development
Table 100. Merck Company Details
Table 101. Merck Business Overview
Table 102. Merck Product
Table 103. Merck Revenue in Therapies and Diagnostics for Cervical Cancer Business (2015-2020) (Million US$)
Table 104. Merck Recent Development
Table 105. Pfizer Company Details
Table 106. Pfizer Business Overview
Table 107. Pfizer Product
Table 108. Pfizer Revenue in Therapies and Diagnostics for Cervical Cancer Business (2015-2020) (Million US$)
Table 109. Pfizer Recent Development
Table 110. Bristol-Myers Squibb Business Overview
Table 111. Bristol-Myers Squibb Product
Table 112. Bristol-Myers Squibb Company Details
Table 113. Bristol-Myers Squibb Revenue in Therapies and Diagnostics for Cervical Cancer Business (2015-2020) (Million US$)
Table 114. Bristol-Myers Squibb Recent Development
Table 115. Digene Company Details
Table 116. Digene Business Overview
Table 117. Digene Product
Table 118. Digene Revenue in Therapies and Diagnostics for Cervical Cancer Business (2015-2020) (Million US$)
Table 119. Digene Recent Development
Table 120. Dendreon Company Details
Table 121. Dendreon Business Overview
Table 122. Dendreon Product
Table 123. Dendreon Revenue in Therapies and Diagnostics for Cervical Cancer Business (2015-2020) (Million US$)
Table 124. Dendreon Recent Development
Table 125. SANOFI Company Details
Table 126. SANOFI Business Overview
Table 127. SANOFI Product
Table 128. SANOFI Revenue in Therapies and Diagnostics for Cervical Cancer Business (2015-2020) (Million US$)
Table 129. SANOFI Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Therapies and Diagnostics for Cervical Cancer Market Share by Type: 2020 VS 2026
Figure 2. Pap Smear Tests Features
Figure 3. Colposcopy Tests Features
Figure 4. ECC Procedure Features
Figure 5. Global Therapies and Diagnostics for Cervical Cancer Market Share by Application: 2020 VS 2026
Figure 6. Drug Manufacturers Case Studies
Figure 7. Hospitals and Clinics Case Studies
Figure 8. Private and Government Research Institutes Case Studies
Figure 9. Academic Institutes Case Studies
Figure 10. Therapies and Diagnostics for Cervical Cancer Report Years Considered
Figure 11. Global Therapies and Diagnostics for Cervical Cancer Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Therapies and Diagnostics for Cervical Cancer Market Share by Regions: 2020 VS 2026
Figure 13. Global Therapies and Diagnostics for Cervical Cancer Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Therapies and Diagnostics for Cervical Cancer Market Share by Players in 2019
Figure 16. Global Top Therapies and Diagnostics for Cervical Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Therapies and Diagnostics for Cervical Cancer as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Therapies and Diagnostics for Cervical Cancer Revenue in 2019
Figure 18. North America Therapies and Diagnostics for Cervical Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Therapies and Diagnostics for Cervical Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Therapies and Diagnostics for Cervical Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Therapies and Diagnostics for Cervical Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Therapies and Diagnostics for Cervical Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Therapies and Diagnostics for Cervical Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Therapies and Diagnostics for Cervical Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
子宮頸がん診断検査の世界市場（～2026年） Market Analysis and Insights: Global Cervical Cancer Diagnostic Test Market The global Cervical Cancer Diagnostic Test market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data i…- 子宮頸がんスクリーニングの世界市場（～2026年） Cervical screening is the process of recognizing and expelling abnormal tissue or cells in the cervix before precancerous cervical lesions or cervical malignancy develops. Continuous growth of cancer‘s impact on Public Health is the primary factor that drives the Cervical Cancer Screening Market. Th…
- 子宮頸部異形成治療の世界市場（～2026年） A precancerous condition where abnormal cell growth occurs at the opening of the cervix is known as cervical dysplasia. Alternatively, it is known as cervical intraepithelial neoplasia. This disease affects the women of all ages but occurs commonly in the age group of 25 to 35 years old. The cervica…
- 子宮頸がんワクチンの世界市場（～2026年） Market Analysis and Insights: Global Cervical Cancer Vaccine Market The global Cervical Cancer Vaccine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Cervical Cancer Vaccine Scope and Market Size Cervical Cancer Vacci…
- 精密がん治療の世界市場（～2026年） Precision cancer therapies is an evolving approach to cancer care that aims to leverage new knowledge regarding the pathogenesis of cancer to more precisely target therapy. Precision cancer medicine utilizes molecular diagnostic testing, including DNA sequencing, to identify cancer-driving abnormali…